// App-Quantinova.ai

1215 : Neurodevelopmental disorders in patients with RYR2-associated catecholaminergic polymorphic ventricular tachycardia

Researchers

Presenter

  • S.R.W. Chen

Principal Investigators

  • J. Till

  • M.J. Ackerman

  • I.M.B. Van Der Laar

  • A.A.M. Wilde

Medical Centers

  • University of Calgary, Department of Medicine and Physiology and Pharmacology, Calgary, Canada

  • Royal Brompton Hospital, Department of Cardiothoracic Surgery, London, United Kingdom

  • Mayo Clinic, Department of Pediatric and Adolescent Medicine, Rochester, United States of America

  • Academic Medical Center, Department of Clinical Chemistry, Amsterdam, Netherlands

  • Academic Medical Center of Amsterdam, Clinical and Experimental Cardiology, Amsterdam, Netherlands

Locations

  • Canada

  • United Kingdom

  • Netherlands

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Genetic Disorder

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A